Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03TIJ
|
|||
| Former ID |
DIB006854
|
|||
| Drug Name |
Titanocene dichloride
|
|||
| Synonyms |
MKT-4
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Discontinued in Phase 2 | [1] | |
| Company |
Medac GmbH
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H10Cl2Ti
|
|||
| Canonical SMILES |
[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Cl-].[Cl-].[Ti+4]
|
|||
| InChI |
1S/2C5H5.2ClH.Ti/c2*1-2-4-5-3-1;;;/h2*1-5H;2*1H;/q2*-1;;;+4/p-2
|
|||
| InChIKey |
YMNCCEXICREQQV-UHFFFAOYSA-L
|
|||
| CAS Number |
CAS 1271-19-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001994) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.